GRP
ALXN

Global Retirement Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Global Retirement Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-55
Closed -$10K – 2102
2021
Q2 		$10K Buy
55
+3
+6% +$515 ﹤0.01% 1387
2021
Q1 		$8K Sell
52
-102
-66% -$15.8K ﹤0.01% 1369
2020
Q4 		$24K Sell
154
-47
-23% -$6.04K ﹤0.01% 979
2020
Q3 		$23K Hold
201
– – ﹤0.01% 886
2020
Q2 		$23K Buy
201
+68
+51% +$7.22K ﹤0.01% 867
2020
Q1 		$12K Buy
133
+32
+32% +$3.14K ﹤0.01% 998
2019
Q4 		$11K Hold
101
– – ﹤0.01% 1140
2019
Q3 		$10K Hold
101
– – ﹤0.01% 1137
2019
Q2 		$13K Hold
101
– – ﹤0.01% 1053
2019
Q1 		$14K Buy
101
+50
+98% +$6.22K ﹤0.01% 965
2018
Q4 		$5K Hold
51
– – ﹤0.01% 1187
2018
Q3 		$7K Hold
51
– – ﹤0.01% 1155
2018
Q2 		$6K Buy
+51
New +$5.96K ﹤0.01% 1180
2017
Q2 		– Sell
-22
Closed -$3K – 1186
2017
Q1 		$3K Hold
22
– – ﹤0.01% 1005
2016
Q4 		$3K Buy
+22
New +$2.69K ﹤0.01% 937

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Global Retirement Partners's ALXN Position: Q3 2021 in Review

Global Retirement Partners sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 55 shares — an estimated $10K sold.

Global Retirement Partners first reported a position in ALXN in Q4 2016 and held it in 15 quarters. The position peaked at $24K in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Global Retirement Partners reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Global Retirement Partners sold 55 Alexion Pharmaceuticals shares in Q3 2021, an estimated $10K.
  • Global Retirement Partners first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 15 quarters.
  • Global Retirement Partners's Alexion Pharmaceuticals position peaked at $24K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Global Retirement Partners's 13F filing for Q3 2021, filed 22 Oct 2021.